241 related articles for article (PubMed ID: 26790669)
1. Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients.
Otsuka K; Imanishi Y; Tada Y; Kawakita D; Kano S; Tsukahara K; Shimizu A; Ozawa H; Okami K; Sakai A; Sato Y; Ueki Y; Sato Y; Hanazawa T; Chazono H; Ogawa K; Nagao T
Ann Surg Oncol; 2016 Jun; 23(6):2038-45. PubMed ID: 26790669
[TBL] [Abstract][Full Text] [Related]
2. [Survival analysis and immunohistochemical study of HER-2 and AR (androgen receptor) expression in salivary duct carcinoma].
Otsuka K; Imanishi Y; Habu N; Sato Y; Shigetomi S; Fujii R; Sakamoto K; Tomita T; Fujii M; Kameyama K; Ogawa K
Nihon Jibiinkoka Gakkai Kaiho; 2013 Sep; 116(9):1024-32. PubMed ID: 24191589
[TBL] [Abstract][Full Text] [Related]
3. Parotid salivary duct carcinoma: a single institution's 20-year experience.
Stodulski D; Mikaszewski B; Majewska H; Kuczkowski J
Eur Arch Otorhinolaryngol; 2019 Jul; 276(7):2031-2038. PubMed ID: 31062093
[TBL] [Abstract][Full Text] [Related]
4. The impact of clinicopathological factors on clinical outcomes in patients with salivary gland adenoid cystic carcinoma: a multi-institutional analysis in Japan.
Kawakita D; Murase T; Ueda K; Kano S; Tada Y; Tsukahara K; Okami K; Onitsuka T; Fujimoto Y; Matoba T; Sakurai K; Nagao T; Hanai N; Kawata R; Hato N; Nibu KI; Urano M; Taguchi KI; Nakaguro M; Kusafuka K; Yamamoto H; Nagao T; Inagaki H
Int J Clin Oncol; 2020 Oct; 25(10):1774-1785. PubMed ID: 32613404
[TBL] [Abstract][Full Text] [Related]
5. Salivary duct carcinoma.
Hosal AS; Fan C; Barnes L; Myers EN
Otolaryngol Head Neck Surg; 2003 Dec; 129(6):720-5. PubMed ID: 14663441
[TBL] [Abstract][Full Text] [Related]
6. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
Gilbert MR; Sharma A; Schmitt NC; Johnson JT; Ferris RL; Duvvuri U; Kim S
JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):489-95. PubMed ID: 26939990
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and outcome analysis of salivary duct carcinoma.
Han MW; Roh JL; Choi SH; Nam SY; Lee HJ; Cho KJ; Lee SW; Kim SY
Auris Nasus Larynx; 2015 Dec; 42(6):472-7. PubMed ID: 26028371
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases.
Jaehne M; Roeser K; Jaekel T; Schepers JD; Albert N; Löning T
Cancer; 2005 Jun; 103(12):2526-33. PubMed ID: 15900577
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland.
Al-Qahtani KH; Tunio MA; Bayoumi Y; Gurusamy VM; Bahamdain FA; Fatani H
J Otolaryngol Head Neck Surg; 2016 May; 45(1):32. PubMed ID: 27184361
[TBL] [Abstract][Full Text] [Related]
10. A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands.
Boon E; Bel M; van Boxtel W; van der Graaf WTA; van Es RJJ; Eerenstein SEJ; Baatenburg de Jong RJ; van den Brekel MWM; van der Velden LA; Witjes MJH; Hoeben A; Willems SM; Bloemena E; Smit LA; Oosting SF; ; Jonker MA; Flucke UE; van Herpen CML
Int J Cancer; 2018 Aug; 143(4):758-766. PubMed ID: 29492965
[TBL] [Abstract][Full Text] [Related]
11. [Salivary duct carcinoma--a clinicopathological analysis of five cases].
Bień S; Sygut J; Kopczyński J; Postuła S; Ziółkowska M
Otolaryngol Pol; 2007; 61(1):33-8. PubMed ID: 17605416
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of adjuvant therapy on the prognosis of ductal carcinoma of the major salivary gland: a large-scale cohort study.
Zhang D; Li L; Wen T; Ma F
Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):409-417. PubMed ID: 36036273
[TBL] [Abstract][Full Text] [Related]
13. Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis.
Haderlein M; Scherl C; Semrau S; Lettmaier S; Hecht M; Erber R; Iro H; Fietkau R; Agaimy A
Strahlenther Onkol; 2017 Nov; 193(11):961-970. PubMed ID: 28828496
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
Monteiro LS; Bento MJ; Palmeira C; Lopes C
J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
[TBL] [Abstract][Full Text] [Related]
15. Cervical Lymph Node Metastatic Status and Adjuvant Therapy Predict the Prognosis of Salivary Duct Carcinoma.
Qian K; Di L; Guo K; Zheng X; Ji Q; Wang Z
J Oral Maxillofac Surg; 2018 Jul; 76(7):1578-1586. PubMed ID: 29544756
[TBL] [Abstract][Full Text] [Related]
16. Brain metastases in patients with salivary duct carcinoma: A retrospective study.
Fushimi C; Takahashi H; Kawakita D; Kano S; Tsukahara K; Ozawa H; Okami K; Sakai A; Yamazaki K; Okada T; Hanazawa T; Sato Y; Imanishi Y; Shimizu A; Matsuki T; Nagao T; Tada Y
Cancer Med; 2024 Mar; 13(5):e7037. PubMed ID: 38477487
[TBL] [Abstract][Full Text] [Related]
17. [Salivary duct carcinoma of the sublingual gland--a case report].
Sartorius C; Gille F; Bédrossian-Pfingsten J; Kempf HG
Laryngorhinootologie; 2006 Jul; 85(7):517-9. PubMed ID: 16586279
[TBL] [Abstract][Full Text] [Related]
18. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group.
Terhaard CH; Lubsen H; Van der Tweel I; Hilgers FJ; Eijkenboom WM; Marres HA; Tjho-Heslinga RE; de Jong JM; Roodenburg JL;
Head Neck; 2004 Aug; 26(8):681-92; discussion 692-3. PubMed ID: 15287035
[TBL] [Abstract][Full Text] [Related]
19. Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications.
Santana T; Pavel A; Martinek P; Steiner P; Grossmann P; Baněčková M; Skálová A
Hum Pathol; 2019 Nov; 93():37-47. PubMed ID: 31437521
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological analysis of 40 cases of salivary duct carcinoma].
Lin N; Cai JH; Xu MJ; Kang P; Cheng ZF; He W
Zhonghua Kou Qiang Yi Xue Za Zhi; 2019 Jun; 54(6):416-419. PubMed ID: 31177683
[No Abstract] [Full Text] [Related]
[Next] [New Search]
